Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-05-10
2005-05-10
Chan, Christina (Department: 1644)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S325000, C435S320100
Reexamination Certificate
active
06891027
ABSTRACT:
Coupling of C3d molecules or ligands of CD21 or CD19 to an antigen alters the level of immune response to the immunogen upon its administration to an individual. For C3d, the magnitude of the effect is dependent on the number of C3d molecules included in the conjugate. Conveniently, C3d molecules or CD21/CD19 ligands are coupled to an immunogen in fusion polypeptides which may be produced by expression from coding nucleic acid, for instance by culturing host cells containing the nucleic acid. Other means of associating the molecules include chemical cross-linking and co-expression on the surface of a carrier structure. Administration of compositions comprising, in a preferred embodiment, C3d molecules and an immunogen of interest may be used prophylactically (by virtue of the immunological memory induced) or therapeutically. The administration may be for the purpose of raising antibodies to the immunogen. A T-cell response may also be induced.
REFERENCES:
patent: 5225538 (1993-07-01), Capon et al.
patent: 5331090 (1994-07-01), Lernhardt et al.
patent: 5866694 (1999-02-01), Katinger et al.
patent: 9102536 (1991-03-01), None
patent: 9113974 (1991-09-01), None
patent: 9116437 (1991-10-01), None
Metzler et al. (1997) Nature Structural Biol. 4(7):527-531.*
Nilsson et al (Biochem J. (1992) 282:715-721.*
Mold et al., “CR2 is a Complement Activator and the Covalent Binding Site for C3 During Alternative Pathway Activation by Raji Cells,”The Journal of Immunology, 140(6):2934-2934 (1988).
Hebell et al., “Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes,”Science, 254(5028):102-105 (1991).
Dempsey and Fearon, “Creating Supra- and Infra-Immunogenic Forms of Antigen by Fusion with C3d,” 9th International Congress of Immunology, p. 581, Jul. 23-29, 1995.
Klein,Immunology. The Science of Self-Nonself Discrimination, New York, Wiley & Sons, pp. 335, 339 and 343, 1982.
Griffioen, A.W., et al., “Pneumococcal Polysaccharides Complexed with C3d Bind to Human B Lymphocytes via Complement Receptor Type 2”,Infect. Immun.59(5):1839-1845 (May 1991).
Dempsey Paul W.
Fearon Douglas T.
Cambridge University Technical Services Limited
Chan Christina
Dorsey & Whitney LLP
Trecartin Richard F.
VanderVegt F. Pierre
LandOfFree
Modulating the immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulating the immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulating the immune response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3382516